FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageno.nhn.fhir.helsenorge.profiles
Resource TypeSchedule
IdSchedule-Schedule-Koronavaksine.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: Schedule Schedule-Koronavaksine

Periode for første og siste ledige slot i timebok

  • freePlanningHorizon: 2024-06-05 09:00:00+0000 --> 2024-06-09 15:30:00+0000

identifier: Uniform Resource Identifier (URI)/urn:uuid:03b4a6cf-7c8b-4171-a171-8b7abbec2eaf

serviceType: Koronavaksine

actor: Koronavaksine (Identifier: urn:oid:2.16.578.1.12.4.1.1.9051/ABCDEF123456)

comment: Koronavaksine tilbys til risikopasienter i henhold til retningslinjer fra FHI


Source1

{
  "resourceType": "Schedule",
  "id": "Schedule-Koronavaksine",
  "meta": {
    "profile": [
      "http://helsenorge.no/fhir/StructureDefinition/hn-basis-schedule"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "extension": [
        {
          "url": "freePlanningHorizon",
          "valuePeriod": {
            "start": "2024-06-05T09:00:00Z",
            "end": "2024-06-09T15:30:00Z"
          }
        }
      ],
      "url": "http://helsenorge.no/fhir/StructureDefinition/hn-extension-free-slot-planningHorizon"
    }
  ],
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:uuid:03b4a6cf-7c8b-4171-a171-8b7abbec2eaf"
    }
  ],
  "serviceType": [
    {
      "coding": [
        {
          "system": "urn:oid:2.16.578.1.12.4.1.1.7617",
          "code": "Koronavaksine"
        }
      ]
    }
  ],
  "actor": [
    {
      "type": "HealthcareService",
      "identifier": {
        "system": "urn:oid:2.16.578.1.12.4.1.1.9051",
        "value": "ABCDEF123456"
      },
      "display": "Koronavaksine"
    }
  ],
  "comment": "Koronavaksine tilbys til risikopasienter i henhold til retningslinjer fra FHI"
}